Measures of genotype versus gene products: Promise and pitfalls in cancer prevention

Carcinogenesis

Volumn 24, Issue 9, 2003, Pages 1429-1434

  Ahsan, Habibul ^a,b   Rundle, Andrew G ^a,b  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYTOCHROME P450 1A; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; GENE PRODUCT; GLUTATHIONE TRANSFERASE;

BREAST CANCER; CANCER PREVENTION; CANCER RESEARCH; CANCER RISK; COLON CANCER; DIAGNOSTIC PROCEDURE; DNA POLYMORPHISM; FUNCTIONAL ASSESSMENT; GENE FUNCTION; GENETIC ANALYSIS; GENOTYPE; HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

EPIDEMIOLOGY, MOLECULAR; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; POLYMORPHISM, GENETIC; RESEARCH; RISK FACTORS;

EID: 0141721418     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgg104     Document Type: Review

References (72)

1. Lander, E.S., Linton, L.M., Birren, B. et al. (2001) Initial sequencing and analysis of the human genome. Nature, 409, 860-921.
2. Venter, J.C., Adams, M.D., Myers, E.W. et al. (2001) The sequence of the human genome. Science, 291, 1304-1351.
3. Sachidanandam, R., Weissman, D., Schmidt, S.C. et al. (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature, 409, 928-933.
4. Bernal, M.L., Sinues, B., Johansson, I., McLellan, R.A., Wennerholm, A., Dahl, M.L., Ingelman-Sundberg,M. and Bertilsson,L. (1999) Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 genes associated with ultrarapid metabolism of debrisoquine. Pharmacogenetics, 9, 657-660.
5. Rundle, A., Tang, D., Zhou, J., Cho, S. and Perera, F. (2000) The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue. Cancer Epidemiol. Biomarkers Prev., 9, 1079-1085.
6. Weitzel, J.N., Ding, S., Larson, G.P., Nelson, R.A., Goodman, A., Grendys, E.C., Ball, H.G. and Krontiris, T.G. (2000) The HRAS1 minisatellite locus and risk of ovarian cancer. Cancer Res., 60, 259-261.
7. Holden, A.L. (2002) The SNP consortium: summary of a private consortium effort to develop an applied map of the human genome. Biotechniques, 22-4 (suppl.), 26.
8. Roses, A.D. (2002) Genome-based pharmacogenetics and the pharmaceutical industry. Nature Rev. Drug Discov., 1, 541-549.
9. Glatt, C.E., DeYoung, J.A., Delgado, S., Service, S.K., Giacomini, K.M., Edwards, R.H., Risch, N. and Freimer, N.B. (2001) Screening a large reference sample to identify very low frequency sequence variants: comparisons between two genes. Nature Genet., 27, 435-438.
10. Hemminki, K. and Forsti, A. (2002) Proper controls for SNP studies? Carcinogenesis, 23, 1405.
11. Taioli, E. and Garte, S. (2002) Covariates and confounding in epidemiologic studies using metabolic gene polymorphisms. Int. J. Cancer, 100, 97-100.
12. Feldman, E.B. (1997) How grapefruit juice potentiates drug bioavailability. Nutr. Rev., 55, 398-400.
13. Bailey, D.G., Malcolm, J., Arnold, O. and Spence, J.D. (1998) Grapefruit juice-drug interactions. Br. J. Clin. Pharmacol., 46, 101-110.
14. Schrenk, D., Brockmeier, D., Morike, K., Bock, K.W. and Eichelbaum, M. (1998) A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers. Eur. J. Clin. Pharmacol., 53, 361-367.
15. Barnes, S.L., Singletary, K.W. and Frey, R. (2000) Ethanol and acetaldehyde enhance benzo[a]pyrene-DNA adduct formation in human mammary epithelial cells. Carcinogenesis, 21, 2123-2128.
16. Ingelman-Sundberg, M., Johansson, I., Yin, H., Terelius, Y., Eliasson, E., Clot, P. and Albano, E. (1993) Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol, 10, 447-452.
17. Minamoto, T., Mai, M. and Ronai, Z. (1999) Environmental factors as regulators and effectors of multistep carcinogenesis. Carcinogenesis, 20, 519-527.
18. Feinberg, A., Cui, H. and Ohlsson, R. (2002) DNA methylation and genomic imprinting: insights from cancer into epigenetic mechanisms. Semin. Cancer Biol., 12, 389.
19. Baylin, S. and Bestor, T.H. (2002) Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell, 1, 299-305.
20. Reeve, A.E., Becroft, D.M., Morison, I.M. and Fukuzawa, R. (2002) Insulin-like growth factor-II imprinting in cancer. Lancet, 359, 2050-2051.
21. Kim, S.J., Park, S.E., Lee, C., Lee, S.Y., Jo, J.H., Kim, J.M. and Oh, Y.K. (2002) Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II. Biochim. Biophys. Acta, 1586, 307-315.
22. Plass, C. and Soloway, P.D. (2002) DNA methylation, imprinting and cancer. Eur. J. Hum. Genet., 10, 6-16.
23. Strathdee, G. (2002) Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin. Cancer Biol., 12, 373-379.
24. Engel, L. S., Taioli, E., Pfeiffer, R. et al. (2002) Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am. J. Epidemiol., 156, 95-109.
25. Tang, D.L., Rundle, A., Warburton, D., Santella, R.M., Tsai, W.Y., Chiamprasert, S., Hsu, Y.Z. and Perera, F.P. (1998) Associations between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers. Carcinogenesis, 19, 1949-1953.
26. Pastorelli, R., Guanci, M., Cerri, A. et al. (1998) Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide. Cancer Epidemiol. Biomarkers Prev., 7, 703-709.
27. Thier, R., Bruning, T., Roos, P.H. and Bolt, H.M. (2002) Cytochrome P450 1B1, a new keystone in gene-environment interactions related to human head and neck cancer? Arch. Toxicol., 76, 249-256.
28. Hayes, J.D. and Strange, R.C. (2000) Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology, 61, 154-166.
29. Sundberg, K., Dreij, K., Seidel, A. and Jernstrom, B. (2002) Glutathione conjugation and DNA adduct formation of dibenzo[a,l]pyrene and benzo[a]pyrene diol epoxides in V79 cells stably expressing different human glutathione transferases. Chem. Res. Toxicol., 15, 170-179.
30. Sundberg, K., Widersten, M., Seidel, A., Mannervik, B. and Jernstrom,B. (1997) Glutathione conjugation of bay- and fjord-region diol epoxides of polycyclic aromatic hydrocarbons by glutathione transferases M1-1 and P1-1. Chem. Res. Toxicol., 10, 1221-1227.
31. Jernstrom, B., Funk, M., Frank, H., Mannervik, B. and Seidel, A. (1996) Glutathione S-transferase A1-1-catalysed conjugation of bay and fjord region diol epoxides or polycyclic aromatic hydrocarbons with glutathione. Carcinogenesis, 17, 1491-1498.
32. Bartsch, H. and Hietanen, E. (1996) The role of individual susceptibility in cancer burden related to environmental exposure. Environ. Health Perspect., 104 (suppl. 3), 569-577.
33. Duell, E.J., Millikan, R.C., Pittman, G.S., Winkel, S., Lunn, R.M., Tse, C.K., Eaton, A., Mohrenweiser, H.W., Newman, B. and Bell, D.A. (2001) Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol. Biomarkers Prev., 10, 217-222.
34. Vidal, A.E., Boiteux, S., Hickson, I.D. and Radicella, J.P. (2001) XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J., 20, 6530-6539.
35. Caldecott, K.W., McKeown, C.K., Tucker, J.D., Ljungquist, S. and Thompson, L.H. (1994) An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III. Mol. Cell Biol., 14, 68-76.
36. Armstrong, B.K., White, E. and Saracci, R. (1994) Principles of Exposure Measurement in Epidemiology. Oxford University Press, New York.
37. Rebbeck, T.R. (1999) Inherited genetic predisposition in breast cancer. A population-based perspective. Cancer, 86, 2493-2501.
38. Coles, B.F., Anderson, K.E., Doerge, D.R., Churchwell, M.I., Lang, N.P. and Kadlubar, F.F. (2000) Quantitative analysis of interindividual variation of glutathione S-transferase expression in human pancreas and the ambiguity of correlating genotype with phenotype. Cancer Res., 60, 573-579.
39. Rundle, A., Tang, D., Mooney, L., Grumet, S. and Perera, F. (2003) The interaction between alcohol consumption and GSTM1 genotype on PAH-DNA adduct levels in breast tissue. Cancer Epidemiol. Biomarkers Prev., accepted for publication.
40. Spitz, M.R., Fueger, J.J., Halabi, S., Schantz, S.P., Sample, D. and Hsu, T.C. (1993) Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis. Cancer Epidemiol. Biomarkers Prev., 2, 329-333.
41. Tuimala, J., Szekely, G., Gundy, S., Hirvonen, A. and Norppa, H. (2002) Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis, 23, 1003-1008.
42. Wei, Q., Gu, J., Cheng, L., Bondy, M.L., Jiang, H., Hong, W.K. and Spitz, M.R. (1996) Benzo(a)pyrene diol epoxide-induced chromosomal aberrations and risk of lung cancer. Cancer Res., 56, 3975-3979.
43. Willett, W.C. (2002) Balancing life-style and genomics research for disease prevention. Science, 296, 695-698.
44. Rogan, E.G., Badawi, A.F., Devanesan, P.D., Meza, J.L., Edney, J.A., West, W.W., Higginbotham, S.M. and Cavalieri, E.L. (2003) Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis, 24, 697-702.
45. Kabuto, M., Akiba, S., Stevens, R.G., Neriishi, K. and Land, C.E. (2000) A prospective study of estradiol and breast cancer in Japanese women. Cancer Epidemiol. Biomarkers Prev., 9, 575-579.
46. Thomas, H.V., Reeves, G.K. and Key, T.J. (1997) Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes Control, 8, 922-928.
47. Thompson, P.A. and Ambrosone, C. (2000) Molecular epidemiology of genetic polymorphisms in estrogen metabolizing enzymes in human breast cancer. J. Natl Cancer Inst. Monogr., 125-134.
48. Haiman, C.A., Hankinson, S.E., Spiegelman, D., Colditz, G.A., Willett,W.C., Speizer,F.E., Kelsey,K.T. and Hunter,D.J. (1999) The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res., 59, 1015-1020.
49. Ahsan, H., Chen, Y., Whittmore, A.S. et al. (2003) Variants in estrogen-biosynthesis genes CYP17 and CYP19 and breast cancer risk: A family-based genetic association study. Cancer Epidemiol. Biomarkers Prev., in press.
50. Sandhu, M.S., Dunger, D.B. and Giovannucci, E.L. (2002) Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J. Natl Cancer Inst., 94, 972-980.
51. Furstenberger, G. and Senn, H.J. (2002) Insulin-like growth factors and cancer. Lancet Oncol., 3, 298-302.
52. Giovannucci, E. (2001) Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J. Nutr., 131, 3109S-3120S.
53. Djavan, B., Waldert, M., Seitz,C. and Marberger, M. (2001) Insulin-like growth factors and prostate cancer. World J. Urol., 19, 225-233.
54. Yu,H. and Rohan,T. (2000) Role of the insulin-like growth factor family in cancer development and progression. J. Natl Cancer Inst., 92, 1472-1489.
55. Chan, J.M., Stampfer, M.J., Giovannucci, E., Ma, J. and Pollak, M. (2000) Insulin-like growth factor I (IGF-I), IGF-binding protein-3 and prostate cancer risk: epidemiological studies. Growth Horm. IGF. Res., 10 (suppl. A), S32-S33.
56. Pollak, M. (2000) The question of a link between insulin-like growth factor physiology and neoplasia. Growth Horm. IGF. Res., 10 (suppl. B), S21-S24.
57. Pollak, M. (2000) Insulin-like growth factor physiology and cancer risk. Eur. J. Cancer, 36, 1224-1228.
58. Giovannucci, E. (1999) Insulin-like growth factor-I and binding protein-3 and risk of cancer. Horm. Res., 51 (suppl. 3), 34-41.
59. Pollak, M., Beamer, W. and Zhang, J.C. (1998) Insulin-like growth factors and prostate cancer. Cancer Metastasis Rev., 17, 383-390.
60. Figer, A., Karasik, Y.P., Baruch, R.G., Chetrit, A., Papa, M.Z., Sade, R.B., Riezel, S. and Friedman, E. (2002) Insulin-like growth factor I polymorphism and breast cancer risk in Jewish women. Isr. Med. Assoc. J., 4, 759-762.
61. Missmer, S.A., Haiman, C.A., Hunter, D.J., Willett, W.C., Colditz, G.A., Speizer, F.E., Pollak, M.N. and Hankinson, S.E. (2002) A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int. J. Cancer, 100, 332-336.
62. Yu, H., Li, B.D., Smith, M., Shi, R., Berkel, H.J. and Kato, I. (2001) Polymorphic CA repeats in the IGF-I gene and breast cancer. Breast Cancer Res. Treat., 70, 117-122.
63. Perera, F.P. and Weinstein, I.B. (1982) Molecular epidemiology and carcinogen-DNA adduct detection: new approaches to studies of human cancer causation. J. Chronic Dis., 35, 581-600.
64. Lee, J.J., Trizna, Z., Hsu, T.C., Spitz, M.R. and Hong, W.K. (1996) A statistical analysis of the reliability and classification error in application of the mutagen sensitivity assay. Cancer Epidemiol. Biomarkers Prev., 5, 191-197.
65. Prince, J.A., Feuk, L., Howell, W.M., Jobs, M., Emahazion, T., Blennow, K. and Brookes, A.J. (2001) Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation. Genome Res., 11, 152-162.
66. Orlow, I., Roy, P., Barz, A., Canchola, R., Song, Y. and Berwick, M. (2001) Validation of denaturing high performance liquid chromatography as a rapid detection method for the identification of human INK4A gene mutations. J. Mol. Diagn., 31, 158-163.
67. Rinaldi, S., Dechaud, H., Biessy, C. et al. (2001) Reliability and validity of commercially available, direct radioimmunoassays for measurement of blood androgens and estrogens in postmenopausal women. Cancer Epidemiol. Biomarkers Prev., 10, 757-765.
68. Hardy, B.G., Lemieux, C., Walker, S.E. and Bartle, W.R. (1988) Interindividual and intraindividual variability in acetylation: characterization with caffeine. Clin. Pharmacol. Ther., 44, 152-157.
69. Zhang, K., Calabrese, P., Nordborg, M. and Sun, F. (2002) Haplotype block structure and its applications to association studies: power and study designs. Am. J. Hum. Genet., 71, 1386-1394.
70. Thomas, D.C. and Witte, J.S. (2002) Point: population stratification: a problem for case-control studies of candidate-gene associations? Cancer Epidemiol. Biomarkers Prev., 11, 505-512.
71. Cardon, L.R. and Palmer, L.J. (2003) Population stratification and spurious allelic association. Lancet, 361, 598-604.
72. Ng, S.K. (1991) Does epidemiology need a new philosophy? A case study of logical inquiry in the acquired immunodeficiency syndrome epidemic. Am. J. Epidemiol., 133, 1073-1077.